American Nano Silicon Technologies, Inc. - FORM 10-Q

Attached files

file	filename
EXCEL - IDEA: XBRL DOCUMENT - American Nano Silicon Technologies, Inc.	Financial_Report.xls
EX-31.1 - RULE 13A-14(A) CERTIFICATION - American Nano Silicon Technologies, Inc.	americannanoexh311.htm
EX-32.1 - RULE 13A-14(B) CERTIFICATION - American Nano Silicon Technologies, Inc.	americannanoexh321.htm

U. S. Securities and Exchange Commission

Washington, D. C. 20549

FORM 10-Q

	[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended December 31, 2013

	[ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the transition period from _____ to _____

Commission File No. 0-52940

AMERICAN NANO SILICON TECHNOLOGIES, INC. (Name of Registrant in its Charter)

California	33-0726410
(State of Other Jurisdiction of incorporation or organization)	(I.R.S.) Employer I.D. No.)

Nanchong Shili Industrial Street, Economic and Technology Development Zone, Xiaolong Chunfei Industrial Park
(Address of Principal Executive Offices)

Issuer's Telephone Number: 86-817-3634888

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files.) Yes x No o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes o No x

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check One)

Large accelerated filer o Accelerated filer o Non-accelerated filero Smaller reporting company x

APPLICABLE ONLY TO CORPORATE ISSUERS: Indicate the number of shares outstanding of each of the Registrant's classes of common stock, as of the latest practicable date:

Common Voting Stock: 46,917,445 shares as of February 13, 2014

AMERICAN NANO SILICON TECHNOLOGIES, INC.

QUARTERLY REPORT ON FORM 10-Q

FOR THE FISCAL QUARTER ENDED DECEMBER 31, 2013

TABLE OF CONTENTS
		Page No
Part I	Financial Information

Item 1.	Financial Statements (unaudited):

	Consolidated Balance Sheets – December 31, 2013 (Unaudited) and September 30, 2013	2

	Consolidated Statements of Operations and Comprehensive Income (Unaudited) - for the Three Months Ended December 31, 2013 and 2012	3

	Consolidated Statements of Cash Flows (Unaudited) – for the Three Months Ended December 31, 2013 and 2012	4

	Notes to Consolidated Financial Statements (Unaudited)	5

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	12

Item 3	Quantitative and Qualitative Disclosures about Market Risk	16

Item 4.	Controls and Procedures	17

Part II	Other Information

Item 1.	Legal Proceedings	17

Items 1A.	Risk Factors	17

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	17

Item 3.	Defaults upon Senior Securities	17

Item 4.	Mine Safety Disclosures	17

Item 5.	Other Information	17

Item 6.	Exhibits	17

AMERICAN NANO SILICON TECHNOLOGIES, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS

	December 31,			September 30,
	2013			2013
	(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	532,111		$	75,901
Accounts receivable, net		314,922			338,312
Inventory, net of reserve		319,317			433,811
Advance payments		284,178			289,368
Prepaid expense and other receivables		98,839			66,042
Prepaid value-added tax		113,319			123,157
Total Current Assets		1,662,686			1,326,591

Property, plant and equipment, net		22,727,597			22,786,880

Other assets:
Land use rights, net		1,013,326			1,013,848
Total other assets		1,013,326			1,013,848

Total Assets	$	25,403,609		$	25,127,319

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
Accounts payable	$	169,271		$	187,605
Short term loans		6,853,204			5,345,800
Taxes payable		52,213			55,926
Due to related parties		7,427,244			5,500,997
Long term loans-current portion		2,469,542			2,438,187
Accrued expenses and other payables		945,881			1,042,734

Total Current Liabilities		17,917,355			14,571,249

Long-term liabilities
Long term loans		480,324			1,020,224
Due to related parties		-			1,415,868
Total Long Term Liabilities		480,324			2,436,092

Total Liabilities		18,397,679			17,007,341

Commitment and Contingencies

Stockholders' Equity
Common stock, $0.0001 par value, 200,000,000 shares authorized; 46,917,445 shares issued and outstanding as of December 31, 2013 and September 30, 2013, respectively		4,692			4,692
Additional paid-in-capital		14,555,929			14,474,258
Accumulated other comprehensive income		2,339,087			2,291,219
Accumulated deficit		(9,893,777	)		(8,650,191	)
Total Stockholders' Equity		7,005,931			8,119,978

Total Liabilities and Stockholders' Equity	$	25,403,610		$	25,127,319

The accompanying notes are an integral part of these consolidated financial statements.

AMERICAN NANO SILICON TECHNOLOGIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited)

	For the Three Months Ended
	December 31
	2013			2012


Revenues	$	345,870		$	33,396

Cost of Goods Sold		749,960			31,676

Gross Profit(Loss)		(404,090	)		1,720

Operating Expenses
Research and development expense		16,483			-
Selling, general and administrative		244,668			760,220
Total operating expenses		261,151			760,220

Loss from operations		(665,241	)		(758,500	)

Other Income( Expense)
Interest expense - related party		(155,716	)		(29,490	)
Interest expense, net		(424,508	)		(238,427	)
Change in fair value of derivative liabilities		-			358,400
Other income		1,977			222,416
Total other income(expense)		(578,247	)		312,899

Loss Before Income Taxes		(1,243,488	)		(445,601	)

Provision for Income Taxes		98			83

Net Loss		(1,243,586	)		(445,684	)
Other Comprehensive Income (Loss)
Foreign currency translation adjustment		47,868			(61,834	)
Comprehensive Loss	$	(1,195,718	)	$	(507,518	)

Loss per common share
Basic and diluted	$	(0.03	)	$	(0.01	)

Weighted average number of common shares
Basic and diluted		46,917,445			39,061,840

The accompanying notes are an integral part of these consolidated financial statements.

AMERICAN NANO SILICON TECHNOLOGIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)

	Three Months Ended December 31,
	2013			2012

Cash Flows From Operating Activities:
Net Loss	$	(1,243,586	)	$	(445,684	)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of derivative liabilities		-			(358,400	)
Depreciation and amortization		371,452			361,061
Stock based compensation expense		-			-
Imputed interest expense for non interest bearing related party loans		81,671			29,490
Impairment of property, plant and equipment		-			-
Changes in operating assets and liabilities:
Accounts receivable		25,408			(8,440	)
Inventory		116,876			(74,521	)
Advances to suppliers		6,952			(149,787	)
Prepaid expense and other receivables		(32,313	)		(709,347	)
Accounts payable		(19,441	)		(47,736	)
Taxes payable		6,523			(7,934	)
Accrued expenses and other payables		(102,865	)		109,089
Cash used in operating activities		(789,323	)		(1,302,209	)

Cash Flows From Investing Activities:
Additions to property and equipment		(165,775	)		(54,563	)

Cash used in investing activities		(165,775	)		(54,563	)

Cash Flows From Financing Activities
Proceeds from bank note payable		-			714,603
Proceeds (repayment) of related parties loans, net		466,697			(106,454	)
Proceeds from short term loans		1,470,922			476,402
Proceeds (repayment) of long term loans		(527,906	)		1,070,970
Cash provided by financing activities		1,409,713			2,155,521

Effect of exchange rate changes on cash and cash equivalents		1,595			4,109

Increase in cash and cash equivalents		456,210			802,858

Cash and Cash Equivalents - Beginning of the period		75,901			56,661

Cash and Cash Equivalents - End of the period	$	532,111		$	859,519

SUPPLEMENTAL CASH FLOW INFORMATION:
During the period, cash was paid for the following:
Interest expense	$	461,816		$	208,281
Income tax	$	97		$	414

The accompanying notes are an integral part of these consolidated financial statements.

AMERICAN NANO SILICON TECHNOLOGIES, INC.

Notes to Consolidated Financial Statements

(Unaudited)

Note 1 – Organization and Nature of Business

American Nano-Silicon Technologies, Inc. (the “Company” or “ANNO”) was incorporated in the State of California on September 6, 1996. Since 2006, the Company has been primarily engaged in the business of manufacturing and distributing refined consumer chemical products through its subsidiaries, Nanchong Chunfei Nano-Silicon Technologies Co., Ltd. (“Nanchong Chunfei”), Sichuan Chunfei Refined Chemicals Co., Ltd. (“Chunfei Chemicals”), and Sichuan Hedi Veterinary Medicines Co., Ltd. (“Hedi Medicines”).

On May 28, 2013, the Company assigned 10% of the equity in Chunfei Chemicals to each of Mr. Fachun Pu, Mr. Qiwei Zhang and Mr. Jianbo Liu, and assigned 5% of the equity in Hedi Medicines to Mr. Fachun Pu, and the assignees paid to the Company cash equal to the registered equity amount. At the same time, Messrs Pu, Zhang and Liu agreed to hold those equity interests solely for the benefit of the Company, to pay over to the Company any distributions or dividends they receive, to vote their interests as directed by the Company, and to resell the interests to the Company at its option for cash equal to the registered equity amount.

Note 2 – Summary of Significant Accounting Policies

Basis Of Presentation and Consolidation

The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United Stated of America (“US GAAP”). The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.

The unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the unaudited financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the financial position as of December 31, 2013 and the results of operations and cash flows for the three month periods ended December 31, 2013 and 2012. The financial data and other information disclosed in these notes to the interim financial statements related to these periods are unaudited. The results for the three months ended December 31, 2013 are not necessarily indicative of the results to be expected for any subsequent periods or for the entire year ending September 30, 2014. The balance sheet at September 30, 2013 has been derived from the audited financial statements at that date.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to the Securities and Exchange Commission’s rules and regulations. These unaudited financial statements should be read in conjunction with our audited financial statements and notes thereto for the year ended September 30, 2013 as included in our Annual Report on Form 10-K.

Reclassifications

Certain amounts of prior period were reclassified for presentation purposes.

Fair Value of Financial Instruments

The Company adopted the provisions of Accounting Standards Codification (“ASC”) 820, Fair Value Measurements and Disclosures. ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

Level 1- Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

AMERICAN NANO SILICON TECHNOLOGIES, INC.

Notes to Consolidated Financial Statements

(Unaudited)

Note 2 – Summary of Significant Accounting Policies (Continued)

Level 2- Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

Level 3- Inputs are unobservable inputs which reflect the reporting entity’s own assumptions.

The carrying amounts reported in the balance sheets for cash, taxes payable, construction security deposit, due to related parties, prepaid expenses, other receivables, advance to suppliers, short-term loan, accounts payable, advance from customers, other payables and accrued expenses approximate their fair market value based on the short-term nature of these instruments. The carrying value of the long-term debt approximates fair value based on market rates and terms currently available to the Company.

Taxation

Income taxes

The Company accounts for income tax under the provisions of ASC 740-10-25, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of the events that have been included in the financial statements or tax returns. Deferred income taxes are recognized for all significant temporary differences between tax and financial statements bases of assets and liabilities. Valuation allowances will also be established against net deferred tax assets when it is more likely than not that some portion or all of the deferred tax asset will not be realized.

Uncertain tax positions

During the course of business, there are certain transactions and calculations for which the ultimate tax determination is uncertain. We establish reserves for tax-related uncertainties based on estimates of whether, and the extent to which, additional taxes may be due. These reserves are established when we believe that certain positions might be challenged despite our belief that our tax return positions are fully supportable. We adjust these reserves in light of changing facts and circumstances, such as the outcome of a tax audit or changes in the tax law. The provision for income taxes includes the impact of reserve provisions and changes to reserves that are considered appropriate.

Value Added Tax

Value added tax is imposed on goods sold in or imported in the PRC. Value added tax payable in the People’s Republic of China is charged on an aggregated basis at a rate of 13% or 17% (depending on the type of goods involved) on the full price collected for the goods sold or, in the case of taxable services provided, at a rate of 17% on the charges for the taxable services provided, but excluding, in respect of both goods and services, any amount paid in respect of value added tax included in the price or charges, and less any deductible value added tax already paid by the taxpayer on purchases of goods and services in the same financial year. The value added tax refundable for the Company as of December 31, 2013 and September 30, 2013 was $113,319 and $123,157, respectively.

Earnings (Loss) Per Share

Earnings per share are calculated in accordance with the FASB ASC 260, “Earnings per share.” Basic earnings per share are based upon the weighted average number of common shares outstanding, but excluding shares issued as compensation that have not yet vested. Diluted earnings per share are based on the assumption that all dilutive convertible shares and stock options were converted or exercised, and that all unvested shares have vested. Dilution is computed by applying the treasury stock method. Under this method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase common stock at the average market price during the period. Potential common shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS.

AMERICAN NANO SILICON TECHNOLOGIES, INC.

Notes to Consolidated Financial Statements

(Unaudited)

Note 2 – Summary of Significant Accounting Policies (Continued)

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of advances to suppliers and other receivables arising from its normal business activities. The Company does not require collateral or other security to support these receivables. The company routinely assesses the financial strength of its debtors and, based upon factors surrounding the credit risk, establishes an allowance, if required, for uncollectible accounts.

Foreign Currency Translation

The Company’s principal country of operations is the PRC. The financial position and results of operations of the Company are determined using the local currency, Renminbi (“RMB”), as the functional currency. Foreign currency transactions are translated at the applicable rates of exchange in effect at the transaction dates. Monetary assets and liabilities denominated in foreign currencies at the balance sheet date are translated at the applicable rates of exchange in effect at that date. Revenues and expenses are translated at the average exchange rates in effect during the reporting period. Equity accounts are translated in the historical exchange rate when the transactions took place.

Asset and liability accounts at December 31, 2013 and September 30, 2013 were translated at 6.1125 RMB to $1.00 and at 6.1501 RMB to $1.00, respectively, which were the exchange rates on the balance sheet dates. Equity accounts were stated at their historical rate. The average translation rates applied to the statements of income and cash flows for the three months ended December 31, 2013 and 2012 were 6.1275 RMB and 6.2972 RMB to $1.00, respectively.

RMB is not a fully convertible currency. All foreign exchange transactions involving RMB must take place either through the People’s Bank of China (the “PBOC”) or other institutions authorized to buy and sell foreign exchange. The exchange rates adopted for the foreign exchange transactions are the rates of exchange quoted by the PBOC, which are determined largely by supply and demand.

Translation adjustments arising from the use of different exchange rates from period to period are included as a component of stockholders' equity as "Accumulated Other Comprehensive Income". Gain or loss from translation adjustments is included in the statement of operations.

Note 3 – Going Concern

As shown in the accompanying financial statements, the Company’s current liabilities exceed its current assets by $16.3 million as of December 31, 2013. The Company suspended manufacturing operations in May 2011 as part of an effort to relocate the production facilities. The Company resumed limited production on January 2, 2012. The current cash and inventory level will not be sufficient to support the Company’s resumption of its normal operations and repayments of the loans. In addition, the Company has suffered negative cash flows for the past two years. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The Company will need additional funds to meet its operating and financing obligations until sufficient cash flows are generated from anticipated production to sustain operations and to fund future development and financing obligations. We expect, but provide no assurance, that affiliate companies owned by the Company’s largest shareholder and president, Mr. Pu Fachun, will continue to provide necessary funding for the Company’s normal operations. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Note 4 – Inventory

The inventory as of December 31, 2013 and September 30, 2013 consisted of the following:

	December 31, 2013		September 30, 2013

Raw materials	$	58,628	$	128,669
Packing supplies		37,002		40,393
Work in process		109,890		60,032
Finished goods		113,797		204,717
Total	$	319,317	$	433,811

AMERICAN NANO SILICON TECHNOLOGIES, INC.

Notes to Consolidated Financial Statements

(Unaudited)

Note 5 – Related Party Transactions

The Company periodically borrows money from its shareholders to finance the operations. The details of loans from related parties are as follows:

	December 31, 2013		September 30, 2013

Short term:
Chunfei Real Estate	$	1,132,096	$	856,163
Sichuan Chunfei Daily Chemical		484,924		364,723
Sichuan Shubei Feed Co.Ltd.		63,313		16,260
Sichuan Lanmate Technology Co. Ltd.		2,951,848		2,614,811
Jian Zhou, a shareholder		32,720		-
Pu Fachun		2,762,343		1,649,040
Total	$	7,427,244	$	5,500,997

Long term:
Pu Fachun	$	-	$	1,415,868
Total	$	-	$	1,415,868

Sichuan Chunfei Daily Chemicals Co. Ltd (“Daily Chemical”) and Sichuan Chunfei Real Estate (“Chunfei Real Estate”) are owned by Mr. Pu Fachun. Sichuan Shubei Feed Co.Ltd. is owned by Mr. Pu Xidi, son of Mr. Pu Fachun. Sichuan Lanmate Technology Co., Ltd. is owned by Mr. Zhang Qiwei, a member of the Company’s Board of Directors.

The Company recorded imputed interest at 6% per annum and recorded $81,671 and $29,490 for non-interest bearing related party loans for the three months ended December 31, 2013 and 2012, respectively.

Note 6 – Short Term Loans

The short term loans as of December 31, 2013 and September 30, 2013 consisted of the following:

	December 31, 2013		September 30, 2013

a) Loan payable to Nanchong City Bureau of Finance due on demand at fixed interest rate of 0.465% per month	$	654,400	$	650,400

b) Loan payable to Nanchong Commercial Bank due on January 24, 2014, which was paid in full in January 2014, and July 1, 2014, at fixed interest rate of 6.6% per annum, guaranteed by a third party		1,636,000		1,626,000

c) Loan payable to Nanchong Bank of Communications due on July 1, 2014, at floating interest rate, guaranteed by third parties, Mr. Pu Fachun, Zhang Xuchu and Feng Ting, Hedi Medicines		818,000		813,000

d) Individual loans from unrelated parties, which are due on demand and bearing interests from 0% to 72% per annum		3,744,804		2,256,400

Total Short Term Loans	$	6,853,204	$	5,345,800

The Company pledged its land use right and its building and equipment to a third party to secure the bank loans.

AMERICAN NANO SILICON TECHNOLOGIES, INC.

Notes to Consolidated Financial Statements

(Unaudited)

Note 7 – Long Term Loans

The long term loans as of December 31, 2013 and September 30, 2013 consisted of the following:

	December 31, 2013		September 30, 2013

a) Individual loans from unrelated parties at monthly interest rate of 0%-6%	$	2,849,866	$	3,358,411

b)Individual loans from various investors, bearing interest of 12% per annum and due on July 1, 2015, as extended		100,000		100,000

Less: current portion of long term loans		2,469,542		2,438,187

Total Long Term Loans	$	480,324	$	1,020,224

On December 20, 2013, the Company entered into a long term bank loan agreement with Jialing Rural Credit Cooperative Union for $4,744,400(RMB29,000,000). Pursuant to the Loan Agreement, the principle will be paid on December 19, 2015. The monthly interest rate is 8.97%. The loan was secured by Chunfei Chemicals’ real property and Chunfei Real Estate’s real property. During January 2014, the Company received the fund.

Note 8 – Income Taxes

The Company’s subsidiaries are governed by the Income Tax Law of the People’s Republic of China. Their income is taxed at the 25% statutory rate. Hedi Medicine has been taxed at a flat rate of 260 RMB per quarter since calendar 2012.

The following table reconciles the U.S. statutory rates to the Company’s effective tax rate for the three months ended December 31, 2013 and 2012:

	Three Months Ended December 31,
	2013			2012
US statutory income tax rate		35	%		35	%
Non-taxable item in US		0	%		-28	%
Change in valuation allowance - US		-35	%		-7	%
China income tax statutory statutory rate		25	%		25	%
Change in valuation allowance - China		-25	%		-25	%
Effective rate		-			-

As of December 31, 2013, net operating loss carry forwards for United States and China income tax purposes amounted to $2.5 million and $11.5 million, which may be available to reduce future years' taxable income. These carry forwards will expire, if not utilized, beginning in 2028 through 2033 for U.S tax purpose and 2017 to 2018 for China income tax purposes. Management believes that the realization of the benefits arising from the losses recognized in the US is uncertain due to the Company's business operations being primarily conducted in China and foreign income not being recognized in the United States for federal income tax purposes. It is also uncertain that the China business operations will generate taxable income in the future. Accordingly, the Company has provided a 100% valuation allowance as of the balance sheet dates, for the temporary differences related to the loss carry-forwards.

AMERICAN NANO SILICON TECHNOLOGIES, INC.

Notes to Consolidated Financial Statements

(Unaudited)

Note 8 – Income Taxes (Continued)

The following table reconciles the changes in deferred tax asset for the three months ended December 31, 2013 and 2012:

	December 31, 2013			December 31, 2012
United States:
Deferred tax asset-beginning	$	855,293		$	658,622
Addition: loss carry-forward		2,514			177,947
Valuation allowance-beginning		(855,293	)		(658,622	)
Addition: valuation allowance		(2,514	)		(177,947	)

Deferred tax asset net	$	-		$	-

China:
Deferred tax asset-beginning	$	2,084,623		$	185,246
Addition: loss carry-forward		309,077			26,275
Valuation allowance-beginning		(2,084,623	)		(185,246	)
Addition: valuation allowance		(309,077	)		(26,275	)

Deferred tax asset net	$	-		$	-

The Company’s open tax years for its federal and state income tax returns are for the tax years after 2010. These tax returns are subject to examination by the tax authorities.

Note 9 – Earnings (Loss) Per Share

The Company presents earnings (loss) per share on a basic and diluted basis. Basic earnings (loss) per share has been computed by dividing net earnings by the weighted average number of shares outstanding. Diluted earnings (loss) per share has been computed by dividing net earnings by the weighted average number of shares outstanding including the dilutive effect of equity securities. For the three months ended December 31, 2013, the weighted average number of shares calculated for diluted EPS excludes the potential common stock that would be exercised under the warrants granted to investors because of their anti-dilutive effect.

The following is a reconciliation of the basic and diluted earnings (loss) per share computation:

	Three Months Ended December 31,
		2013			2012

Net loss		$	(1,243,586	)	$	(445,684	)

Weighted average common shares (denominator for basic loss per share)			46,917,445			39,061,840

Effect of dilutive securities: Warrants			-			-

Weighted average common shares (denominator for diluted loss per share)			46,917,445			39,061,840

Basic and diluted loss per share		$	(0.03	)	$	(0.01	)

AMERICAN NANO SILICON TECHNOLOGIES, INC.

Notes to Consolidated Financial Statements

(Unaudited)

Note 10 – Risk Factors

Concentrations

For the three months ended December 31, 2013, three customers accounted for 67.7%, 12.8% and 11.3% of total sales, and two vendor accounted for 43.7% and 19.9% of total purchases.

We generated very limited sales and made very limited purchases in the three months ended December 31, 2012. Therefore we did not rely on any particular customer or vendor for the period.

None of the vendors and customers mentioned above is a related party to the Company.

Operations in the PRC

The Company’s operations are carried out in the PRC. Accordingly, the Company’s business, financial condition and results of operations may be influenced by the political, economic and the legal environments in the PRC as well as by the general state of the PRC’s economy. The Company’s business may be influenced by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad, and rates and methods of taxation, among other things.

Note 11 – Commitment and Contingencies

LITIGATION

During the 2013 fiscal year, Jian Zhou, a shareholder, commenced a legal action against American Nano Silicon Technologies, Inc. Mr. Zhou alleges that he is entitled to 857,142 shares of American Nano common stock in connection with the acquisition of Nanchong Chunfei by American Nano in 2007. In response to the allegation, American Nano has asserted that all of the shares to which Mr. Zhou was entitled were issued to him. The trial court has dismissed Mr. Zhou’s claim, and he has appealed the dismissal to the court of appeals.

NOTE 12 –SUBSEQUENT EVENT

The Company has evaluated subsequent events for purposes of recognition or disclosure through the date these financial statements were issued, and has determined that there was no material event that occurred subsequent to December 31, 2013.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT OF OPERATIONS

Forward Looking Statements

This Quarterly Report on Form 10-Q contains "forward-looking" statements as such term is defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements contain information relating to the Company that is based on the beliefs of the Company’s management as well as assumptions made by and information currently

available to the Company’s management. When used in this report, the words “anticipate,” “believe,” “estimate,” “expect” and “intend” and words or phrases of similar import, as they relate to the Company or Company management, are intended to identify forward-looking statements. Such statements reflect the current risks, uncertainties and assumptions related to certain factors including, without limitations, competitive factors, general economic conditions, customer relations, relationships with vendors, the interest rate environment, governmental regulation and supervision, seasonality, distribution networks, product introductions and acceptance, technological change, changes in industry practices, onetime events and other factors. Factors that might cause such forward-looking statements to prove inaccurate include, but are not limited to, those discussed in Item 1A entitled “Risk Factors” of our Annual Report on Form 10-K for the year ended September 30, 2013. Based upon changing conditions, should any one or more of these risks or uncertainties materialize, or should any underlying assumptions prove incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected or intended. The Company assumes no obligation to update these forward-looking statements.

Restructuring of our Operations

In May 2011, the Company began moving to its new factory site located at Nanchong Shili Industrial Street, Economic and Technology Development Zone, Xiaolong Chunfei Industrial Park, which is approximately 12.4 miles from the Company's previous factory site. We expect the new site to provide us an annual manufacturing capacity of approximately 10 million tons. The Company temporarily suspended production to facilitate the move, resulting in a significant decrease in sales beginning in the third quarter of fiscal year 2011. On December 8, 2011, the Company announced that it had successfully relocated to its new facility in Nanchong, Sichuan, China. In addition to housing existing equipment and machinery from its previous facility, ANNO’s latest facility also contains new equipment that enables the Company to increase its product diversification capabilities as well as manufacture its new flame retardant additive product.

Flame retardant additive is a new refined chemical product for the Company, which has very strict standards. We began trial production of the product on January 2, 2012 and during calendar year 2012 conducted several rounds of testing of the quality of the product by asking potential customers for trial use. Through calendar year 2012 we were recalibrating our production process according to feedback received from potential customers. By December 2012 we had satisfied ourselves regarding the quality of our new manufacturing systems, and were prepared to return to normal operations. We commenced commercial production of the flame retardant at the end of January 2013, albeit at a reduced level of production due to our lack of working capital.

During 2012, we signed a contract with a customer to provide 2,000 tons of products a year at a price of $868 per ton. As of December 31, 2013, we had delivered some products to the customer that signed the contract with us, but at a quantity short of that specified in the contract due to shortage of working capital. Because of the inefficiency of operating at a low production level and because of high costs of raw materials, the sales were recorded at a loss. During the three months ended December 31, 2013, the Company recorded $86,245 of revenue from flame retardant additive; the remainder of our revenue was related to our detergent additive.

Critical Accounting Policies

Our consolidated financial information has been prepared in accordance with U.S. GAAP, which requires us to make judgments, estimates and assumptions that affect (1) the reported amounts of our assets and liabilities, (2) the disclosure of our contingent assets and liabilities at the end of each fiscal period and (3) the reported amounts of revenues and expenses during each fiscal period. We continually evaluate these estimates based on our own historical experience, knowledge and assessment of current business and other conditions, our expectations regarding the future based on available information and reasonable assumptions, which together form our basis for making judgments about matters that are not readily apparent from other sources. Some of our accounting policies require a higher degree of judgment than others in their application.

When reviewing our condensed consolidated financial statements, the following should also be considered: (1) our selection of critical accounting policies, (2) the judgment and other uncertainties affecting the application of those policies, and (3) the sensitivity of reported results to changes in conditions and assumptions. In our preparation of the accompanying condensed consolidated financial statements for the three months ended December 31, 2013, there was one estimate made which was (a) subject to a high degree of uncertainty and (b) material to our results. This was:

our determination, described in Note 11 to the financial statements, to record a 100% allowance for our deferred tax assets. The determination to record the allowance with respect to our U.S. deferred tax assets was based on the uncertainty that we would realize income taxable in the U.S. in future years. The determination with respect to our China deferred tax assets was based on the uncertainty that we would realize sufficient income within the requisite time period to utilize the deferred asset.

Results of Operations

Revenues and Gross Profit/Loss

We generated revenue of $345,870 during the three ended December 31, 2013, compared to $33,396 in the three months ended December 31, 2012, an increase of 936% for the three months period. Revenue significantly increased in the three months ended December 31, 2013 because the Company started partial operations in January 2013. During the three months ended December 31, 2012, the equipment and production line in the new facility was undergoing adjustments, and we recorded revenue on sale of sample quantities only. The Company expects to have significant revenue during the remainder of fiscal year 2014.

During the three months ended December 31, 2013, the Company recorded $86,245 in revenue from our flame retardant additive and $259,625 in revenue from our detergent additive.

Our gross loss for the three months ended December 31, 2013 was $404,090 as we haven't yet reached an efficient level of operations.

Selling, General and Administrative Expenses

Our selling, general and administrative, or SG&A, expenses include expenses associated with salaries and other expenses related to marketing and administrative activities. In addition, we have incurred expenses through the use of consultants and other outsourced service providers to take advantage of specialized knowledge and capabilities that we require for short periods of time to avoid unnecessary hiring of full-time staff.

Our SG&A expenses for the three months ended December 31, 2013 were $244,668, compared to $760,220 for the three months ended December 31, 2012, a decrease of 68% for the three months period. SG&A expenses for the three months ended December 31, 2012 were high because the Company did not have any operations during three months ended December 31, 2012 and recorded all depreciation and amortization expenses in SG&A. During the three months ended December 31, 2013, the Company allocated depreciation and amortization between SG&A and cost of goods sold..

Research and Development Expenses

Our business model is based upon developing additional uses for Micro Nano Silicon. Our research and development activities are focused on developing such uses as well as developing nano filtering technology and the production processes for our product.

Since 2011, the focus of our operations has been the move to a new facility. This has distracted us from our research and development activities. For the three months ended December 31, 2013 and 2012, we expended $16,483 and $0, respectively, on research and development. For the three months ended December 31, 2013 and 2012, we incurred less research and development expenses compared to other periods as we focused entirely on initiating the manufacturing of our new product, flame retardant additive.

We believe that the future success of our business depends upon our ability to improve our production processes and develop other usages for Micro Nano Silicon. To avoid product obsolescence, we will continue to monitor technological changes in our industry as well as users' demands for new products. Failure to keep pace with future technological changes could adversely affect our revenues and operating results in the future. Although we believe that Micro Nano Silicon can be utilized in a number of industries, there can be no assurance that we will gain market acceptance of our products in such industries.

Other Income and Expense

As a result of the factors discussed above, we recorded a loss from operations of $665,241 for the three months ended December 31, 2013, compared to $758,500 for the three months ended December 31, 2012. In both quarters, however, non-operating income and expense had a significant effect on our net income.

The primary element of Other Income and Expense during three months ended December 31, 2013 was interest expense relating to loans from bank, unrelated parties and related parties. Interest expense was $580,224 for the three months ended December 31, 2013, an increase of 122% compared to the same periods ended December 31, 2012, as the loans taken to fund the development of our new facility increased our finance charges.

Two events contributed to Other Income in the three months ended December 31, 2012, but were not replicated in 2013:

·	During the three months ended December 31, 2012, the Company received a subsidy of $224,416 from its local government to compensate for land occupied and used by the local government.

·	In March and June 2010 we sold 4 million series B warrants. The warrants permitted the investors to buy additional common shares at the prices specified in the warrant agreements. Because the warrants were subject to down-round protection provision in their terms, the fair value of the warrants was recorded as warrant liabilities on our balance sheet. At the end of each quarter, we re-calculated the fair value of the warrants using the Black-Scholes model, and recorded any increase or decrease in that fair value as other income or other expense. All of the warrants had expired by September 30, 2013. We recorded gains of $358,400 for the three months ended December 31, 2012. We recorded it as unrealized gain from changes in fair value of derivative liabilities in our Statements of Operations as “other income”

Net Loss

Due, primarily, to our gross loss and interest expense, we incurred a net loss of $1,243,586 for the three months ended December 31, 2013, compared to net loss of $445,684 for the three months ended December 31, 2012. Once we fully launch our flame retardant additive product line, we believe that the top line benefits will more than compensate for the increased expenses, and we will realize income from operations in future periods.

Liquidity and Capital Resources

The Company completed construction of its new plant in January 2012, with the exception of one production line, but did not reach a significant level of production until the fourth quarter of fiscal 2013. We expect our affiliate companies will continue to lend the money needed to sustain us through this transition period. Also, we will look for financing from local banks and third parties. However, we did not have any commitments from them. If we are not able to obtain sufficient funds to operate our business, we will not generate sufficient cash flow to repay our short term liabilities.

As a result of recent financing activities, at December 31, 2013 our cash and cash equivalents totaled $532,111. Because all of that financing was short-term debt, and because of our operating loss, our working capital has decreased as shown below:

	December 31, 2013		September 30, 2013
Total current assets	$	1,662,686	$	1,326,591
Total current liabilities		17,917,355		14,571,249
Working capital (deficiency)	$	(16,254,669)	$	(13,244,658)

As of December 31, 2013 we had a working capital deficiency of $16,254,669, representing an increase of $3,010,011 in the deficit during the three months ended December 31, 2013. Our current assets on December 31, 2013 were only $1,662,686, of which only $1,166,350 were liquid. Our current liabilities are primarily composed of short term loans totaling $6,853,204, short term related parties payables totaling $7,427,244 due to Mr. Pu Fachun and entities owned by Mr. Pu Fachun, the single largest shareholder and president of the Company, and $2,469,542 being the current portion of our long term loans. Due to our negative cash flow and working capital deficit, in their report on our financial statements for the year ended September 30, 2013, our auditors expressed substantial doubt about the Company’s ability to continue as a going concern.

The following tables summarize our contractual obligations as of December 31, 2013, and the effect these obligations are expected to have on our liquidity and cash flows in future periods.

	Payments due by period
	Total		Less than 1 year		1-3 Years		3-5 Years		5+ Years

Related parties indebtedness	$	7,427,244	$	7,427,244	$	-	$	-	$	—
Loan payable to unrelated parties		9,803,070		9,322,746		480,324		—		—
Total contractual obligations	$	17,230,314	$	16,749,990	$	480,324	$	-	$	—

Our operations used $789,323 in cash during the three months ended December 31, 2013. Our use of cash fell short of our net loss of $1,243,586, as the net loss included depreciation and amortization expense of $371,452 and imputed interest of $81,671.

We incurred a net loss of $445,684 during the three months ended December 31, 2012 and our operations used $1,302,209 in cash. The disparity was primarily due to the fact that our net loss was reduced by the gain of $358,400 that we recorded as a result of decrease in the fair value of outstanding warrants, as well as the fact that we prepaid $709,347 to our vendors.

For the three months ended December 31, 2013 and 2012, we used $165,775 and $54,563 in investing activities due to additions to property and equipment.

Our financing activities in the three months ended December 31, 2013 included proceeds of $466,697 from related party loans and proceeds from short term loans of $1,470,922.

Our financing activities in the three months ended December 31, 2012 included $714,603 of proceeds from bank note payable, $476,402 of proceeds from short term loans and $1,070,970 of proceeds from long term loans.

As of the date of this report, we do not have sufficient cash to operate for the next 12 months. However, we have a commitment from our president, Mr. Pu Fachun to secure financing through third party loans or personal loans to provide us with sufficient liquidity for the next 12 months.

Off-balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition or results of operations.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

As of December 31, 2013, we carried out an evaluation, under the supervision and with the participation of our management, including our Principal Executive Officer and Principal Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934. Based upon that evaluation, our Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures are not effective in enabling us to record, process, summarize and report information required to be included in our periodic SEC filings within the required time period, due to the lack of expertise in U.S. GAAP accounting among the personnel in our accounting department.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1.	Legal Proceedings
	None.

Item 1A	Risk Factors
	There have been no material changes from the risk factors included in the Annual Report on Form 10-K for the year ended September 30, 2013.

Item 2	Unregistered Sale of Securities and Use of Proceeds

	(a) Unregistered sales of equity securities
	The Company did not effect any unregistered sale of equity securities during the first quarter of fiscal 2014.

	(c) Purchases of equity securities
	The Company did not repurchase any of its equity securities that were registered under Section 12 of the Securities Exchange Act during the first quarter of fiscal 2014.

Item 3.	Defaults Upon Senior Securities.
	None.

Item 4.	Mine Safety Disclosures.
	Not Applicable.

Item 5.	Other Information.
	None.

Item 6.	Exhibits

31	Rule 13a-14(a) Certification

32	Rule 13a-14(b) Certification

101.INS	XBRL Instance

101.SCH	XBRL SchemaXsXBRL Schema

101.CAL	XBRL Calculation

101.DEF	XBRL Definition

101.LAB	XBRL Label

101.PRE	XBRL Presentation

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

American Nano Silicon Technologies, Inc.

Date : February 13, 2014	/s/Pu Fachun
	Pu Fachun, Chief Executive Officer
	and Chief Financial and Accounting Officer

American Nano Silicon Technologies, Inc. - FORM 10-Q - February 13, 2014

Attached files

American Nano Silicon Technologies, Inc. Reports